Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...

Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Survivors of childhood cancers are at increased risk for worse health outcomes throughout their life, but have worse rates of healthy aging with older age at diagnosis.

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Early-onset colorectal cancer is more likely to be diagnosed in people of Black or Hispanic race/ethnicity and be at a later stage at diagnosis.

At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...

Investigators created a prognostic digital pathology-based AI score to identify a subset of patients with clinically high-risk prostate cancer more likely to benefit from the addition of abiraterone ...